Pharmaceutical industry sponsorship and research outcome and quality: systematic review.

@article{Lexchin2003PharmaceuticalIS,
  title={Pharmaceutical industry sponsorship and research outcome and quality: systematic review.},
  author={Joel Lexchin and Lisa A. Bero and Benjamin Djulbegovic and Ot{\'a}vio Clark},
  journal={BMJ},
  year={2003},
  volume={326 7400},
  pages={1167-70}
}
OBJECTIVE To investigate whether funding of drug studies by the pharmaceutical industry is associated with outcomes that are favourable to the funder and whether the methods of trials funded by pharmaceutical companies differ from the methods in trials with other sources of support. METHODS Medline (January 1966 to December 2002) and Embase (January 1980 to December 2002) searches were supplemented with material identified in the references and in the authors' personal files. Data were… CONTINUE READING
588 Citations
78 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 588 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 78 references

The time to register randomized trials

  • R Horton, R. Smith
  • BMJ 1999;319:865-6. (Accepted
  • 2003

Third generation oral

  • JM Kemmeren, A Algra, DE. Grobbee
  • Med 2002;156:1034-41
  • 2002

The association between funding by commercial interests and study outcome in randomized controlled drug trials

  • BM Massie, D Rothenberg
  • Family Practice
  • 2001

Similar Papers

Loading similar papers…